Trial NCT00418574

View at ClinicalTrials.gov 
Org. Study IDs: ABA-01
Secondary IDs: 2006-002801-30 AGO-OVAR 10

Last trial update was posted on 2011-11-24

MeSH Interventions

Abagovomab

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Ovarian Cancer

Stopping Reasons

No benefit on primary end point (RFS); no rationale to collect survival data

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID